| Trial ID: | L0904 |
| Source ID: | IRCT2014020316348N2
|
| Associated Drug: |
L-carnitine
|
| Title: |
L-carnitine effect in the treatment of non alcoholic fatty liver disease in typ 2 diabetic patients and comparision with placebo
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non alcoholic fatty liver disease. <br>Other specified inflammatory liver diseases;Other specified inflammatory liver diseases
|
| Interventions: |
Intervention 1: IN intervention group: 750 mg L- carnitine, three times a day for three months. Intervention 2: IN control group: plasebo three times a day for three months.;Treatment - Drugs;Placebo;IN intervention group: 750 mg L- carnitine, three
|
| Outcome Measures: |
Liver aminotransferase. Timepoint: Before intervention and three months after initiation of the intervention. Method of measurement: Eliza.Serum level of triglicirid and cholestril. Timepoint: Before intervention and three months after initiation of the intervention. Method of measurement: Eliza.;Fasting blood glucos test. Timepoint: Before intervention and three months after initiation of the intervention. Method of measurement: Eliza.
|
| Sponsor/Collaborators: |
Gastroentrology Recerch Center, Ahwaz Jundishapur Medical School
|
| Gender: |
All
|
| Age: |
14 years90 years
|
| Phases: |
Not applicable
|
| Enrollment: |
30
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
10/03/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/15322
|
